MPH Share Buyback has had zero effect; near 52 week lowFor a company with a truckload of cash & profitable--MPH shares are trading like i'ts in the dumpster. So much for buying back and cancelling shares--MPH is near it's 52 week lows. Guess we are in slow-growth mode--that israeli firm's product redds has already been on the US market prior to Medicure & hasn't managed anything substantial. Besides aggrastat--the other generics are providing minimal revenues. Friessen needs to start paying a dividend to attact investment--share buybacks aren't working.